[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]  aponia_analytics [@AponiaAnalytics](/creator/twitter/AponiaAnalytics) on x 5028 followers Created: 2025-07-20 17:20:58 UTC 🦉 Sulfonylurea and insulin use in DM may blunt weight reduction from GLP-1 agonists. Insulin promotes fat storage, opposing the catabolic effects of semaglutide. #GLP1 #diabetes $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS  XXX engagements  **Related Topics** [manat](/topic/manat) [$hims](/topic/$hims) [$vani](/topic/$vani) [$zldpf](/topic/$zldpf) [$rhhby](/topic/$rhhby) [$gsk](/topic/$gsk) [$sny](/topic/$sny) [$lly](/topic/$lly) [Post Link](https://x.com/AponiaAnalytics/status/1946983686815035637)
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
aponia_analytics @AponiaAnalytics on x 5028 followers
Created: 2025-07-20 17:20:58 UTC
🦉 Sulfonylurea and insulin use in DM may blunt weight reduction from GLP-1 agonists. Insulin promotes fat storage, opposing the catabolic effects of semaglutide.
#GLP1 #diabetes $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS
XXX engagements
Related Topics manat $hims $vani $zldpf $rhhby $gsk $sny $lly
/post/tweet::1946983686815035637